These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 37874738)

  • 1. Elegant Nematodes Improve Our Understanding of Human Neuronal Diseases, the Role of Pollutants and Strategies of Resilience.
    von Mikecz A
    Environ Sci Technol; 2023 Nov; 57(44):16755-16763. PubMed ID: 37874738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tire components, age and temperature accelerate neurodegeneration in C. elegans models of Alzheimer's and Parkinson's disease.
    Limke A; Scharpf I; Blesing F; von Mikecz A
    Environ Pollut; 2023 Jul; 328():121660. PubMed ID: 37080524
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exposome, Molecular Pathways and One Health: The Invertebrate
    von Mikecz A
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012346
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Caenorhabditis elegans as an experimental tool for the study of complex neurological diseases: Parkinson's disease, Alzheimer's disease and autism spectrum disorder.
    Calahorro F; Ruiz-Rubio M
    Invert Neurosci; 2011 Dec; 11(2):73-83. PubMed ID: 22068627
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Elucidating the molecular and developmental biology of parasitic nematodes: Moving to a multiomics paradigm.
    Ma G; Wang T; Korhonen PK; Hofmann A; Sternberg PW; Young ND; Gasser RB
    Adv Parasitol; 2020; 108():175-229. PubMed ID: 32291085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurodegenerative disorders: insights from the nematode Caenorhabditis elegans.
    Dimitriadi M; Hart AC
    Neurobiol Dis; 2010 Oct; 40(1):4-11. PubMed ID: 20493260
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of the amyloid-β peptide in a single pair of C. elegans sensory neurons modulates the associated behavioural response.
    Sinnige T; Ciryam P; Casford S; Dobson CM; de Bono M; Vendruscolo M
    PLoS One; 2019; 14(5):e0217746. PubMed ID: 31150491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C. elegans models of age-associated neurodegenerative diseases: lessons from transgenic worm models of Alzheimer's disease.
    Link CD
    Exp Gerontol; 2006 Oct; 41(10):1007-13. PubMed ID: 16930903
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Insights from Caenorhabditis elegans on the role of metals in neurodegenerative diseases.
    Martinez-Finley EJ; Avila DS; Chakraborty S; Aschner M
    Metallomics; 2011 Mar; 3(3):271-9. PubMed ID: 21210060
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life span-resolved nanotoxicology enables identification of age-associated neuromuscular vulnerabilities in the nematode Caenorhabditis elegans.
    Piechulek A; von Mikecz A
    Environ Pollut; 2018 Feb; 233():1095-1103. PubMed ID: 29031405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The nematode Caenorhabditis elegans: a versatile model for the study of proteotoxicity and aging.
    Volovik Y; Marques FC; Cohen E
    Methods; 2014 Aug; 68(3):458-64. PubMed ID: 24794346
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Caenorhabditis elegans model system for amylopathy study.
    Duan Z; Sesti F
    J Vis Exp; 2013 May; (75):e50435. PubMed ID: 23711592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic and Pharmacological Discovery for Alzheimer's Disease Using Caenorhabditis elegans.
    Griffin EF; Caldwell KA; Caldwell GA
    ACS Chem Neurosci; 2017 Dec; 8(12):2596-2606. PubMed ID: 29022701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Watching worms whither: modeling neurodegeneration in C. elegans.
    Wolozin B; Gabel C; Ferree A; Guillily M; Ebata A
    Prog Mol Biol Transl Sci; 2011; 100():499-514. PubMed ID: 21377635
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sir-2.1 modulates 'calorie-restriction-mediated' prevention of neurodegeneration in Caenorhabditis elegans: implications for Parkinson's disease.
    Jadiya P; Chatterjee M; Sammi SR; Kaur S; Palit G; Nazir A
    Biochem Biophys Res Commun; 2011 Sep; 413(2):306-10. PubMed ID: 21889494
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Modeling neurodegenerative diseases in Caenorhabditis elegans.
    Li J; Le W
    Exp Neurol; 2013 Dec; 250():94-103. PubMed ID: 24095843
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ameliorative effect of Luffa cylindrica fruits on Caenorhabditis elegans and cellular models of Alzheimer's disease-related pathology via autophagy induction.
    Long T; Chen X; Qin DL; Zhu YF; Zhou YJ; He YN; Fu HJ; Tang Y; Yu L; Huang FH; Wang L; Yu CL; Law BY; Wu JM; Wu AG; Zhou XG
    Phytother Res; 2023 Oct; 37(10):4639-4654. PubMed ID: 37394882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of the Mitochondrial Unfolded Protein Response Induces Non-Apoptotic Dopaminergic Neurodegeneration in
    Martinez BA; Petersen DA; Gaeta AL; Stanley SP; Caldwell GA; Caldwell KA
    J Neurosci; 2017 Nov; 37(46):11085-11100. PubMed ID: 29030433
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct functional roles of Vps41-mediated neuroprotection in Alzheimer's and Parkinson's disease models of neurodegeneration.
    Griffin EF; Yan X; Caldwell KA; Caldwell GA
    Hum Mol Genet; 2018 Dec; 27(24):4176-4193. PubMed ID: 30508205
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small molecule inhibitors of α-synuclein oligomers identified by targeting early dopamine-mediated motor impairment in C. elegans.
    Chen KS; Menezes K; Rodgers JB; O'Hara DM; Tran N; Fujisawa K; Ishikura S; Khodaei S; Chau H; Cranston A; Kapadia M; Pawar G; Ping S; Krizus A; Lacoste A; Spangler S; Visanji NP; Marras C; Majbour NK; El-Agnaf OMA; Lozano AM; Culotti J; Suo S; Ryu WS; Kalia SK; Kalia LV
    Mol Neurodegener; 2021 Nov; 16(1):77. PubMed ID: 34772429
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.